Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCann Group Ltd

Cann Group Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.005 AUD -0.00 ( 9.09%)
Last update at 2026-11-06T04:07:00Z
VOLUME
1188107
Market Cap
9.13M
P/E
0.28

Momentum Score

…

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cann Group Ltd is an Australian medicinal cannabis company that cultivates, manufactures and supplies cannabis-derived medicines and related products for domestic and export markets. Long-term growth may be supported by rising global medical cannabis demand, export expansion under Australian licensing and scale-up of GMP manufacturing and product development; investors may find the company attractive because it appears positioned to commercialize integrated cultivation-to-manufacturing capabilities.
Key risks include regulatory and pricing uncertainty across jurisdictions, competitive supply and margin pressure, operational and cultivation variability, and potential need for additional financing to support growth.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
9.65M
Revenue Per Share
0.01
Gross Profit TTM
5.99M
Debt / Equity
0.59
ROE
157.35%
Net Debt
16.35M
ROCE
-26.91%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 19.56M -22.34M -51.24M -33.79M -26.47M
Net income 20.30M -22.34M -51.24M -33.79M -26.47M
Selling general administrative - 3.72M 30.44M 33.19M 25.13M
Selling and marketing expenses - 9.60M 13.91M - -
Gross profit -8.06M 5.15M -21.75M 13.78M 6.41M
Reconciled depreciation - - 11.04M 11.96M 4.80M
Ebit -12.02M -16.38M -46.57M -29.96M -24.64M
Ebitda -6.16M -8.94M -35.54M -18.00M -19.84M
Depreciation and amortization 5.86M 7.44M 11.04M 11.96M 4.80M
Operating income -12.02M -8.94M -27.50M -29.73M -24.25M
Other operating expenses 20.58M 22.20M 42.87M -51.27M -35.88M
Interest expense 5.12M 6.00M 6.82M 3.16M 1.83M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 5.96M 6.88M 4.43M 2.22M
Net interest income - - -6.82M -3.16M -1.83M
Income tax expense -0.74M - -2.15M 9.78M 6.26M
Total revenue 8.56M 13.25M 15.37M 13.78M 6.41M
Total operating expenses 3.96M 14.10M 42.87M 50.36M 35.48M
Cost of revenue 16.62M 8.10M 37.13M - -
Total other income expense net 31.58M -13.40M -23.74M 5.95M 4.43M
Net income from continuing ops - - -51.24M -33.79M -26.47M
Net income applicable to common shares - -22.34M -51.24M -33.79M -26.47M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 51.99M 78.79M 92.77M 129.47M 139.66M
Intangible assets - 0.01M - 0.21M 0.79M
Other current assets 0.25M 4.63M 0.35M 2.60M 1.64M
Total liab 23.39M 81.56M 78.93M 70.20M 54.76M
Total stockholder equity 28.61M -2.77M 13.84M 59.26M 84.90M
Other current liab 2.15M 3.97M 2.65M 0.43M 0.16M
Common stock 197.72M 187.95M 182.90M 177.37M 169.43M
Capital stock - - - 177.37M 169.43M
Retained earnings -171.51M -191.82M -169.47M -118.23M -84.44M
Other liab - - - 0.14M 0.10M
Good will - - - - 0.67M
Other assets - - - 0.51M 0.09M
Cash 0.49M 0.01M 1.64M 0.77M 1.91M
Cash and equivalents - - - 0.77M 1.91M
Total current liabilities 7.33M 80.92M 78.25M 24.39M 11.30M
Current deferred revenue 0.51M - 0.18M 0.82M 0.81M
Net debt 16.35M 75.83M 70.91M 60.20M 45.25M
Short term debt 1.03M 75.37M 72.05M 15.29M 3.80M
Short long term debt - - - 15.29M 3.50M
Short long term debt total 16.84M 75.84M 72.55M 60.97M 47.16M
Other stockholder equity 1.68M - - -59.14M -84.98M
Property plant equipment - - - 107.40M 118.20M
Total current assets 7.27M 9.57M 16.26M 21.20M 19.17M
Long term investments - - - 0.14M 0.74M
Net tangible assets - - - 59.05M 83.44M
Net receivables 1.14M 0.59M 4.08M 5.64M 4.16M
Long term debt - - - 45.67M 43.36M
Inventory 5.40M 4.34M 10.19M 12.20M 11.46M
Accounts payable 3.64M 1.57M 3.38M 7.85M 6.52M
Accumulated other comprehensive income 0.73M 1.09M 0.41M 0.12M -0.08M
Non currrent assets other - - 0.04M -107.75M 0.09M
Non current assets total 44.72M 69.22M 76.51M 108.26M 120.50M
Capital lease obligations - - - - 0.30M
Long term debt total - - - 45.67M 43.36M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - 1.18M -0.03M -45.16M
Change to liabilities - - - 1.87M -3.97M
Total cashflows from investing activities -0.41M -0.16M 1.18M -0.03M -45.16M
Net borrowings - - 10.36M 13.80M 46.48M
Total cash from financing activities 2.22M 8.17M 14.77M 21.71M 64.41M
Change to operating activities - - - -0.74M 0.26M
Net income 20.30M -22.34M -51.24M -33.79M -26.47M
Change in cash 0.48M -1.63M 0.88M -1.15M -1.19M
Begin period cash flow 0.01M 1.64M 0.77M 1.91M 3.10M
End period cash flow 0.49M 0.01M 1.64M 0.77M 1.91M
Total cash from operating activities -1.33M -9.64M -15.19M -22.84M -20.43M
Issuance of capital stock - - 4.46M 7.92M 17.92M
Depreciation 5.86M 7.44M 11.04M 11.60M 4.46M
Other cashflows from investing activities - 0.00M 3.68M 3.07M 0.00M
Change to inventory 0.59M 4.20M 1.25M -0.46M 1.44M
Change to account receivables 1.62M 1.31M 2.28M -2.10M 0.06M
Sale purchase of stock - 2.83M 4.46M 7.92M 17.92M
Other cashflows from financing activities -0.06M 0.75M -0.04M 17.30M 46.48M
Change to netincome - - - 0.42M 3.46M
Capital expenditures 0.41M 0.16M 2.50M 3.10M 45.16M
Change in working capital 3.43M 5.04M 5.29M -2.56M 1.50M
Stock based compensation - 0.33M 0.18M 0.19M 0.74M
Other non cash items -30.92M -0.10M 19.56M -0.65M 1.58M
Free cash flow -1.74M -9.80M -17.69M -25.94M -65.60M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CAN
Cann Group Ltd		 -0.00
9.09%		 0.01 0.28 - 0.95 0.29 2.83 0.77
AFP
Aft Pharmaceuticals Ltd		 -
-%		 3.59 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 -
-%		 2.70 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 -
-%		 0.06 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.40 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Cann Group Ltd

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

23 Greentek Court, Mildura, VIC, Australia, 3501

61 3 9095 7088

https://www.canngrouplimited.com

Name Title Year Born
Mr. Peter Crock M.B.A., MBA Chief Exec. Officer NA
Ms. Deborah Ambrosini B.Com., F.C.A. CFO & Company Sec. 1974
Mr. Shane Duncan Chief Operating Officer NA
Mr. Geoff Aldred Chief Projects & Information Officer NA
Mr. Clive Fanning Head of Investor Relations NA
Mr. Steven Notaro Head of Legal NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…